ERBB2 and breast cancer: We also found a similar effect of quercetin in Akt/mTOR inhibition and AMPK activation in the triple negative MDA-MB-231 and HER2 positive MDA-MB-435 cells, suggesting that quercetin is effective in diverse BC subtypes.